找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatitis Viruses; J.-H. James Ou Book 2002 Kluwer Academic Publishers 2002 Hepatitis.antigen.antiviral drug.infection.virus.hepatology.in

[復制鏈接]
樓主: negation
31#
發(fā)表于 2025-3-26 22:26:04 | 只看該作者
32#
發(fā)表于 2025-3-27 03:20:22 | 只看該作者
Antiviral Agents for Hepatitis Viruses,etely from this disease, elderly patients have a substantial high mortality risk. Fulminant hepatitis is a rare complication of acute HAV infection (.). Superinfection by HAV in patients with preexisting liver diseases is often associated with more severe liver disease and increased morbidity and mortality (.).
33#
發(fā)表于 2025-3-27 05:30:33 | 只看該作者
Book 2002 there were two types of hepatitis that weretransmitted either enterically or parenterally. It became apparent inthe 1970‘s that there were additional hepatitis viruses distinct fromhepatitis A and hepatitis B, and thus, the term non-A, non-B hepatitiswas introduced. The non-A, non-B hepatitis was f
34#
發(fā)表于 2025-3-27 12:15:13 | 只看該作者
35#
發(fā)表于 2025-3-27 17:35:17 | 只看該作者
The Molecular Biology of GB Viruses,age of the filterable GB agent was described in non-human primates (., .). This agent, originally obtained from a surgeon experiencing acute hepatitis, was inoculated into tamarins that later developed acute biochemical hepatitis. Although the disease could be further passaged in these animals, isolation of the putative agent remained elusive.
36#
發(fā)表于 2025-3-27 19:28:54 | 只看該作者
37#
發(fā)表于 2025-3-28 00:06:36 | 只看該作者
rstellen. Werden die Erwartungen (über-) erfüllt, so stellt sich bei dem Individuum Zufriedenheit ein.. Andernfalls ist Unzufriedenheit die Konsequenz einer aus Sicht des Individuums nicht befriedigenden Leistung.
38#
發(fā)表于 2025-3-28 05:07:34 | 只看該作者
39#
發(fā)表于 2025-3-28 07:13:31 | 只看該作者
The Molecular Biology of Hepatitis C Virus,carcinoma. There is no vaccine to prevent hepatitis C infection. Prolonged treatment of chronically HCV-infected patients with interferon-α (IFN-α) alone, or in combination with the nucleoside analogue ribavirin is the only currently approved therapy, although poor response rates often accompany these treatment regimens.
40#
發(fā)表于 2025-3-28 13:45:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 05:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
苗栗市| 昌江| 原阳县| 广平县| 微山县| 商城县| 桃江县| 德安县| 惠州市| 华安县| 林西县| 呈贡县| 镇雄县| 浙江省| 科技| 曲松县| 永清县| 巴青县| 平遥县| 大姚县| 延吉市| 峨山| 横峰县| 柞水县| 孟州市| 郴州市| 武功县| 育儿| 依安县| 米易县| 博湖县| 盐城市| 始兴县| 清镇市| 托克逊县| 昌邑市| 洛扎县| 仁怀市| 安顺市| 海南省| 桓仁|